Cargando…
Harnessing endogenous pathways and metabolites to treat or prevent neurodegenerative disease
Autores principales: | Golde, Todd E, Felsenstein, Kevin, Chakrabarty, Paramita, Li, Andy, Moore, Brenda, In, Jung Joo, Cruz, Pedor, Price, Ashely, Borchelt, David, Janus, Christopher, Cebballos-Diaz, Carolina, Rosario, Awilda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3846712/ http://dx.doi.org/10.1186/1750-1326-8-S1-O36 |
Ejemplares similares
-
Amyloid β peptides overexpression in retinal pigment epithelial cells via AAV-mediated gene transfer mimics AMD-like pathology in mice
por: Prasad, Tuhina, et al.
Publicado: (2017) -
Capsid Serotype and Timing of Injection Determines AAV Transduction in the Neonatal Mice Brain
por: Chakrabarty, Paramita, et al.
Publicado: (2013) -
Normal cognition in transgenic BRI2-Aβ mice
por: Kim, Jungsu, et al.
Publicado: (2013) -
Microglia show differential transcriptomic response to Aβ peptide aggregates ex vivo and in vivo
por: McFarland, Karen N, et al.
Publicado: (2021) -
Cholestenoic acid, an endogenous cholesterol metabolite, is a potent γ-secretase modulator
por: Jung, Joo In, et al.
Publicado: (2015)